000 | 01809 a2200481 4500 | ||
---|---|---|---|
005 | 20250516143921.0 | ||
264 | 0 | _c20131203 | |
008 | 201312s 0 0 eng d | ||
022 | _a1551-4005 | ||
024 | 7 |
_a10.4161/cc.24550 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDiep, Caroline H | |
245 | 0 | 0 |
_aProgesterone receptors induce FOXO1-dependent senescence in ovarian cancer cells. _h[electronic resource] |
260 |
_bCell cycle (Georgetown, Tex.) _cMay 2013 |
||
300 |
_a1433-49 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aCellular Senescence _xdrug effects |
650 | 0 | 4 |
_aCyclin-Dependent Kinase Inhibitor p21 _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aForkhead Box Protein O1 |
650 | 0 | 4 |
_aForkhead Transcription Factors _xgenetics |
650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
650 | 0 | 4 |
_aGreen Fluorescent Proteins _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aModels, Biological |
650 | 0 | 4 |
_aOvarian Neoplasms _xgenetics |
650 | 0 | 4 |
_aProgestins _xpharmacology |
650 | 0 | 4 |
_aPromoter Regions, Genetic _xgenetics |
650 | 0 | 4 |
_aProtein Binding _xdrug effects |
650 | 0 | 4 |
_aReceptors, Progesterone _xgenetics |
650 | 0 | 4 | _aTumor Stem Cell Assay |
650 | 0 | 4 |
_aUp-Regulation _xdrug effects |
700 | 1 | _aCharles, Nathan J | |
700 | 1 | _aGilks, C Blake | |
700 | 1 | _aKalloger, Steve E | |
700 | 1 | _aArgenta, Peter A | |
700 | 1 | _aLange, Carol A | |
773 | 0 |
_tCell cycle (Georgetown, Tex.) _gvol. 12 _gno. 9 _gp. 1433-49 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4161/cc.24550 _zAvailable from publisher's website |
999 |
_c22658577 _d22658577 |